Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.

Related Articles Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research. World J Gastroenterol. 2016 Dec 28;22(48):10502-10511 Authors: Buanes TA Abstract Chemotherapy with improved effect in patients with metastatic pancreatic cancer has recently been established, launching a new era for patients with this very aggressive disease. FOLFIRINOX and gemcitabine plus nab-paclitaxel are different regimens, both capable of stabilizing the disease, thus increasing the number of patients who can reach second line and even third line of treatment. Concurrently, new windows of opportunity open for nutritional support and other therapeutic interventions, improving quality of life.…
Origen: Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research. – PubMed